Micronutrients as therapeutic tools in the management of sickle cell disease, malaria and diabetes

African Journal of Biotechnology

Volumn 4, Issue 13 SPEC. ISS., 2005, Pages 1568-1579

  Okochi, V I ^a   Okpuzor, J ^a  

^a UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

Anemia oxidative stress; Diabetes; Immune system; Malaria; Micronutrients; Sickle cell disease

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CAROTENOID; CHROMIUM; COPPER; CYANOCOBALAMIN; FOLIC ACID; FREE RADICAL; IRON; MAGNESIUM; MANGANESE; NICOTINAMIDE; NICOTINIC ACID; PYRIDOXINE; RETINOL; SELENIUM; THIAMINE; TRACE ELEMENT; VANADIUM; VITAMIN B GROUP; ZINC;

ANEMIA; B LYMPHOCYTE; DIABETES MELLITUS; DIET; ERYTHROCYTE MEMBRANE; HEALTH CARE DELIVERY; HUMAN; HYPOGLYCEMIA; IMMUNE SYSTEM; LYMPHOCYTE FUNCTION; MALARIA; NONHUMAN; OXIDATIVE STRESS; REVIEW; SICKLE CELL ANEMIA;

HARNESS;

EID: 29644446641     PISSN: 16845315     EISSN: 16845315     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Aarsand AK, Carlsen SM (1998). Folate administration reduces circulating homocysteine levels in NIDDM patients on long-term metformin treatment. J. Int. Med. 244: 169-174.
2. Ajayi OA, George BO, Ipadeola T (1993). Clinical trial of riboflavin in sickle cell disease. East Afr. Med. J. 70: 418-421.
3. Anderson RA (1998). Chromium, glucose intolerance and diabetes. J. Am. Col Nutr. 17: 548-555.
4. Angeles-Agdeppa I, Schultink W, Sastroamidjojo S, Gross R, Karyadi D (1997). Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents Am. J. Clin. Nutr. 66: 177-83.
5. Baliga BS, Reynolds T, Fink LM, Fonesca VA (2000). Hyperhomocysteinemia in type 2 diabetes mellitus: Cardiovascular risk factors and effect of treatment with folic acid and pyridoxine. Endocrinol. Pract. 5: 435 -441.
6. Ballas SK (2000). Short report: Hydration of sikle erythrocytes using herbal extract (Pfaffa paniculata) in vito. Br. J. Haematol. 111:359-362.
7. Bloem MW, Wedel M, Egger RJ (1989). Iron metabolism and vitamin A deficiency in children in northeast Thailand. Am. J. clin. Nutr. 50: 332-8.
8. Bloem MW, Wedel M, van Agtmaal EJ, Speek AJ, Saowakontha S, Schreurs WHP (1990). Vitamin A intervention: Short-term effects of a single, oral, massive dose on iron metabolism. Am. J. Clin. Nutr. 51: 76-9.
9. Brugnara C (1999). Erythrocyte magnesium deficiencies in sickle cell diseases and beta thalassemia: Role of dietary supplementation. Workshop on Nutrient Metabolism in genetic Anemias, NHLBI, May 24-25, Bethesda MD.USA.
10. Bunn HF (1997). Pathogenesis and treatment of sickle cell disease. New Engl. J. Med. 337: 762-769.
11. Busysschaert M, Drais AS, Wallemacq PE, Hermans MP (2000). Hyperhomocysteinemia in type 2 diabetes: Relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care. 23: 1816-1822.
12. Cam MC, Brownsey RW, McNeill JH (2000). Mechanisms of vanadium action: Insulin mimetic or insulin - enhancing agent? Can. J. Physiol. Pharmacol. 78: 829-847.
13. Cam MC, Browney RW, Rodrigues B, McNeill JH (2001). Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats. Metabolism 50(6): 674-80.
14. Chan A (1999). Interaction of antioxidant nutrients and implications for genetic anemia.Workshop on Nutrient Metabolism in genetic Anemias, NHLBI, May 24-25, Bethesda MD. USA.
15. Crawley J (2003). Tackling the problem of anaemia in malaria endemic regions of Africa. Second update on malaria from WHO's Roll Back Malaria Department.
16. st edition CBS Publishers and Distributors India. pp. 5-9.
17. De Valk H (1999). Magnesium in diabetes mellitus. J. Med. 54: 139-46.
18. Duggen C, Macleod WB, Krebs NF, Westcott JL, Fawzi WW, Premji ZG, Mwanakasale V, Simon JL, Yeboah-Antwi K, Kamer DH, The Zn against Plasmodium study group (2005). Plasma Zinc concentrations are depressed during the acute phase response in children with Falciparum Malaria. J. Nutr. 135: 802-807.
19. th. 2002 on the Internet.
20. Gera T, Sachdev HPS (2000). Effect of Iron supplementation on incidence of infectious illness in children: Systematic review. BMJ. 325(7373): 1142-44.
21. Gibson RS (1994). Content and bioavailability of trace elements in vegetarian diets. Am. J. Clin. Nutr. 59(suppl):1223S -1232S.
22. Greenwood BM, Bojang K, Whitty CJM, Targett GAT (2005). Malaria. Lancet 365:1487-98.
23. Hambidge KM (1997). Zinc deficiency in young children. Am. J. Clin. Nutr. 65: 160-161.
24. Harland BF, Harden-Williams BA (1998). Is vanadium of nutritional importance yet? J. Am. Diet Assoc. 94: 891-894.
25. Hoogeveen EK, Kostense PJ, akobs C, Dekker JM, Nijpels G, Heine RJ, Bouter Lm, Stehouwer CDA, (2000).Hyperhomocysteinemia increase risk of death, especially in type 2 diabetes: 5 year follow-up of the Hoon study. Circulation 101: 1506-1511. http://orthomolecular.org/nutrients/micronutrients.shtml
26. Hypponen E (2002). Micronutrients and the risk of type 1 diabetes: Vitamin D, vitamin E and nicotinamide. Nutr. Rev. 62(9): 340-7.
27. INACG (1999). Safety of iron supplementation programs in malaria - endemic regions. INACG. Consensus Statement. ILSI press, Washington DC, USA. ASS/SCN (1999).
28. Iwu MM (1993). A handbook on African Medicinal Plants CRC Press. pp.137.
29. Malik P (1999). Nutrition and hematopoiesis: An overview. Workshop on Nutrient Metabolism in genetic Anemias, NHLBI, May 24-25, Bethesda MD.USA.
30. Mandel S, Packer L, Youdim MB, Weinreb O (2005). Proceedings from the Third International conference on mechanism of action of nutraceuticals". J. Nutr. Biochem. 16(9): 513-20.
31. Masawe AE, Andy JM, Swai GBR (1974). Infections in iron deficiency and other types of anaemia in the tropics. Lancet 2: 314-317.
32. Metzger A, Mukasa G, Shankar AH, Ndeez G, Melikian G, Semba RD (2001). Antioxidant status and acute malaria in children in Kampala, Uganda. Am. J. Trop. Med. Hyg. 65: 115-119.
33. Mertz W (1998). Interaction of chromium with insulin: A progress report. Nutr. Rev. 56: 174-177.
34. Muller O, Becher H, van Zweeden AB, Ye Y, Diallo DA, Konate AT, Gbangou A, Kouyate B, Garenne M (2001). Effect of zinc supplementation on malaria and other causes of morbidity in West African children: Randomized double blind placebo controlled trial. BMJ 322 (7302): 1567-70.
35. Natta CL, Machlin LJ, Brin M (1980). A decrease in irreversibly sickle cell anemia patients given vitamin E. Am. J. Clin. Nutr. 33: 968-971.
36. Nwanyanwu OC, Ziba C, Kazemba PN, Gamadzi G, Gondwe J, Redd SC (1996). The effect of oral iron therapy during treatment for Plasmodium falciparum malaria with sulphadoxin-primehamine on Malawian children under 5 years of age. Ann. Trop. Med. Parasitol. 90: 589-595.
37. O'Connell BS (2001). Select Vitamins and Minerals in the Management of Diabetes. Diabetes Spectrum 14: 133-148.
38. O'Dell BL (2000). Role of zinc in plasma membrane function. J. Nutr. 130: 1432s-1436s.
39. Ohnishi ST, Ohnishi T (2001). In vitro effects of aged garlic extract and other nutritional supplements on sickle cell erythrocytes. J. Nutr. 131: 1085S-92S.
40. Ohnishi ST, Ohnishi T, Ogunnola GB (2000). Sickle cell anemia: A potential approach for a molecular disease. Nutrition 16: 330-8.
41. Ohnishi ST, Ogunmola GB (1999). Overview: Membrane therapy of molecular disease. Workshop on Nutrient Metabolism in genetic Anemias , NHLBI, May 24-25, Bethesda MD, USA.
42. Prasad AS, Schoomaker EB, Ortega J, Brewer GJ, Oberleas D, Oelshlegel JR (1975). Zinc deficiency in sickle cell disease. Clinical chem. 21: 582-587.
43. Prasad AS (1993). Clinical spectrum of human zinc deficiency. In: Prasad AS (ed.). Biochemistry of zinc. New York, Plenum press. pp. 219-258.
44. Prasad AS (1999). Zinc and Trace minerals. Workshop on Nutrient Metabolism in genetic Anemias , NHLBI, May 24-25, Bethesda MD, USA.
45. Polidori MC, Mecocci P, Stahl W, Parente B, Cecchetti R, Cherubini A, Cao P, Sies H, Senin U (2000). Plasma levels of lipophilic antioxidants in very old patients with type 2 diabetes. Diabetes Metab. Res. Rev. 16: 15-19.
46. Poucheret P, Verma S, Grynpas MD, McNeil JH (1998). Vanadium and diabetes. Mol. Cell Biol. 188: 73-80.
47. Salardi S, Cacciari E, Sassi S, Grossi G, Mainetti B, Casa CD, Pirazzoli P, Cicognani A, Gualandi S (2000). Homocysteinemia, serum folate and vitamin B12 in very young patients with diabetes mellitus type 1. J. Pediatr Endcrinol. Metab. 13: 1621-1627.
48. Salonen JT, Nyyssonen K, Tuomainen TP, Maenpaa PH, Korpel H, Kaplan GA, Lynch J, Helmrich SP, Salonen R (1995). Increased risk of non-insulin-dependent diabetes mellitus at low plasma vitamin E concentrations: A four-year study in men. BMJ 311: 1124-1127.
49. Sarubin A (2000). The Health Profesional's Guide to popular Dietary Supplements. Chicago, The American Dietetic Association.
50. Schultink W, Gross R, Gliwiitzki M, Karyardi D, Matulessi P (1995). Effect of daily vs twice weekly iron supplementation in Indonesian preschool children with low iron status. Am. J. Clin. Nutr. 61: 111-5.
51. Semba RD (1994). Vitamin A, Immunity and Infection. Clin. Infect. Dis. 19: 489-99.
52. Semba RD (1999). Vitamin A and immunity to viral and protozoan infections. Proceedings of the Nutrition Society. 58(3): 719-27.
53. Serghides L, Kain KC (2002). Mechanism of protection induced by vitamin A in falciparum malaria. Lancet. 359:1404-6.
54. Shankar AH, Prasad AS (1998). Zinc and immune function: The biological basis of altered resistance to infection. Am. J. Clin. Nutr. 68(suppl): 4478-63S.
55. Shils ME, Olson JA, Shike M, Ross AC (1999). Eds: Modern Nutrition in Health and disease. 9th. Edition. Phildelphia Pa. Lea & Febiger.
56. Sies H, Stahl W, Sevanian ( 2005). Nutritional, dietary and postprandial oxidative stress. J. Nutr. 135(5): 969-72.
57. Singhal A (1999). Nutrition issues in patients with sickle cell disease. Workshop on Nutrient Metabolism in genetic Anemias, NHLBI, May 24-25, Bethesda MD, USA.
58. Stabler SP, Estacio R, Jeffers BW, Cohen JA, Allen RH, Schrier RW (1999). Total homocysteine is associated with neuropathy in non-insulin dependent diabetes mellitus. Metabolism 48: 1096-1101.
59. Suharno D, West CE, Muhilal Karyadi D, Hautvast JG (1993). Supplementation with vitamin A and iron for nutritional anemia in pregnant women in West Java, Indonesia. Lancet 342: 1325-8.
60. Wambebe C, Khamofu H, Momoh JAF, Ekpenyong M, Audu BS, Njoku OS, Bamgboye EA, Nasipuri RN, Kunle OO, Okogun JI, Enwerem MN, Audam JG, Gamaniel KS, Obodozie OO, Samuel B, Fajule G and Ogunyale O (2001). Double blind placebo-controlled, randomized crossover clinical trial of NIPRISAN in patients with sickle cell disorder. Phytomedicine 8: 252-261.
61. Welch GN, Loscalizo J (1998). Homocysteine and atherothrombosis. New Engl. J. Med. 338: 1042-1050.
62. Welch RM, Graham RD ( 2005). Agriculture: The real nexus for enhancing bioavailable micronutrients in food crops. J. Trace Elem. Med. Biol. 18 (4): 299-307.
63. Whethers DL (1999). Introduction and overview of the problem.WHO Expert Committee on Malaria (1998). Technical report Series 889.
64. Wise A (1995). Phytate and zinc bioavailabilty. Int. J. Food Sci. Nutr. 46: 53-63.
65. Young M, Berti P, FritzGerald S (2000). Insecticide Treated Nets and Vitamin A Supplementation: An integrated approach to control malaria and micronutrient deficiency. Literature review and Malawi case study. The Micronutrient Initiative workshop report.
66. Zemel BS, Kawchak DA, Fung EB, Ohene-Frempong K, Stalling VA (2002). Effect of Zinc supplementation on growth and body composition in children with sickle cell disease. Am. J. Cl. Nutr. 75(2): 300-307.